The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9

Cancer

Volumn 86, Issue 3, 1999, Pages 492-497

  McKiernan, James M ^a   Buttyan, Ralph ^a   Bander, Neil H ^b,c   De La Taille, Alexandre ^a   Stifelman, Michael D ^a   Emanuel, Eric R ^a   Bagiella, Emilia ^d   Rubin, Mark A ^a   Katz, Aaron E ^a   Olsson, Carl A ^a   Sawczuk, Ihor S ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Columbia University ^*  (United States)

Author keywords

MN CA9; Polymerase chain reaction; Renal cell carcinoma; Tumor marker

Indexed keywords

MESSENGER RNA; MN CA9 ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER STAGING; CELL TYPE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; ISOENZYMES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0033179586     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990801)86:3<492::AID-CNCR18>3.0.CO;2-R     Document Type: Article

References (24)

1. Landis HS, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-10.
2. Maldazys JD, DeKernion JB. Prognostic factors in metastatic renal cell carcinoma. J Urol 1986;136:376-9.
3. Saiki RK, Scharf S, Galoona F. Enzymatic amplification of beta globin genomic sequences and restriction site analysis of diagnosis of sickle cell anemia. Science 1985;230:1350-4.
4. Wu A, Ben-Ezra J, Colombero A. Detection of micrometastasis in breast cancer by the polymerase chain reaction. Lab Invest 1990;62:109A.
5. Van Dongen GA, Biakenhoff RM, Van Brink CT, Van Guy FB, de Bree R, Quak JJ, et al. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. Anticancer Res 1996;16:2409-13.
6. Stevens GL, Scheer WD, Levine EA. Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiol Prev 1996;5:293-6.
7. Miller WH, Levine K, DeBlasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcriptase polymerase chain reaction assay for the PML/RAR-fusion mRNA. Blood 1993;82:1689-94.
8. Burchill SA, Bradbury MF, Pittmann K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
9. Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88.
10. Opavsky R, Pastorekova S, Zelnik V, Gibadulinova A, Stanbridge EJ, Zavada J, et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 1996;33: 480-7.
11. Liao SY, Brewer C, Zavada J, Pastorek J, Pastorekova S, Manetta A, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598-609.
12. McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Chen MW, et al. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res 1997;57:2362-6.
13. Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997;57:2827-31.
14. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43:765-75.
15. Chomenzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, New York: Cold Springs Harbor Laboratory Press, 1989:810.
17. Bander NH, Finstad CL, Cordon-Cardo C, Ramsawak RD, Vaughan ED Jr., Whitmore WF Jr., et al. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res 1989;4:6774-80.
18. Ljungberg B, Rasmusen T, Glankuist K. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Eur Urol 1992;21:160-3.
19. Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J, et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 1995; 45:211-7.
20. Gross AJ, Michl VH, Bornhoft G, Diechmann KP. Neuron specific enolase: a serum tumor marker in renal cell carcinoma? Eur Urol 1993;24:397-9.
21. Kusama K, Asano M, Moro I, Sekine T, Kazikoe T, Tobisu K, et al. Tumor markers in human renal cell carcinoma. Tumor Biol 1991;12:189-97.
22. Junker U, Knoefel B, Nuske K, Rebstock K, Steiner T, Wunderlich H, et al. Transforming growth factor beta-1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 1996;8:794-8.
23. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992;187:620-6.
24. Zavada J, Zavadova Z, Machon O, Kutinova L, Nemeckova S, Opavsky R, et al. Transient transformation of mammalian cells by MN protein, a tumor-associated cell adhesion molecule with carbonic anhydrase activity. Int J Oncol 1997;10: 857-63.